The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Setdikova G.R.

Vladimirsky Moscow Regional Research Clinical Institute

Stepanova E.A.

M.F. Vladimirsky Moscow Regional Clinical Research Institute

Verbovsky A.N.

Vladimirsky Moscow Regional Research Clinical Institute

Semenkov A.V.

Moscow Regional Research and Clinical Institute («MONIKI»);
I.M. Sechenov First Moscow State Medical University

Synchronous primary multiple cancer: distal cholangiocarcinoma of the intrapancreatic common bile duct and intraductal papillary mucinous tumor associated with ductal adenocarcinoma of the pancreatic tail

Authors:

Setdikova G.R., Stepanova E.A., Verbovsky A.N., Semenkov A.V.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2024;(8): 57‑63

Read: 1524 times


To cite this article:

Setdikova GR, Stepanova EA, Verbovsky AN, Semenkov AV. Synchronous primary multiple cancer: distal cholangiocarcinoma of the intrapancreatic common bile duct and intraductal papillary mucinous tumor associated with ductal adenocarcinoma of the pancreatic tail. Pirogov Russian Journal of Surgery. 2024;(8):57‑63. (In Russ.)
https://doi.org/10.17116/hirurgia202408157

Recommended articles:

References:

  1. Rungsakulkij N, Boonsakan P. Synchronous gallbladder and pancreatic cancer associated with pancreaticobiliary maljunction. World Journal of Gastroenterology. 2014;20(39):14500-14504. https://doi.org/10.3748/wjg.v20.i39.14500
  2. Taniai T, Haruki K, Shiba H, Onda S, Sakamoto T, Yanaga K. Simultaneous Resection for Synchronous Double Primary Cancers of the Pancreas and the Liver. Case Reports in Gastroenterology. 2018;12(2):504-512.  https://doi.org/10.1159/000490658
  3. Eriguchi N, Aoyagi S, Hara M, Okuda K, Tamae T, Fukuda S, Hashino K, Sato S, Fujiki K, Furukawa S, Jimi A. Synchronous or metachronous double cancers of the pancreas and other organs: report on 12 cases. Surgery Today. 2000;30(8):718-721.  https://doi.org/10.1007/s005950070083
  4. Sastry A, Wayne M, Steele J, Iskandar M, Yuan S, Cooperman AM. Three synchronous, sporadic and separate periampullary and pancreatic tumors: more than a coincidence? World Journal of Surgical Oncology. 2014;12:382.  https://doi.org/10.1186/1477-7819-12-382
  5. Nanashima A, Kondo H, Nakashima M, Abo T, Arai J, Ishii M, Hidaka S, Kunizaki M, To K, Takeshita H, Yamasaki N, Tsuchiya T, Nagayasu T. Clinicopathological characteristics of multiple primary cancers in hepatobiliary and pancreas malignancies. Anticancer Research. 2015;35(2):1073-1083.
  6. Yamamura K, Hashimoto D, Kitano Y, Kuroda D, Eto T, Arima K, Kaida T, Miyata T, Nakagawa S, Imai K, Yamashita YI, Chikamoto A, Matsumura F, Baba H. Multiple Primary Cancers in Patients with Pancreatic Cancer. American Surgeon. 2018;84(12):e514-e516.
  7. Shin SJ, Park H, Sung YN, Yoo C, Hwang DW, Park JH, Kim KP, Lee SS, Ryoo BY, Seo DW, Kim SC, Hong SM. Prognosis of Pancreatic Cancer Patients with Synchronous or Metachronous Malignancies from Other Organs Is Better than Those with Pancreatic Cancer Only. Cancer Research and Treatment. 2018;50(4):1175-1185. https://doi.org/10.4143/crt.2017.494
  8. Likhvantsev VV, Zabelina TS, Grebenchikov OA, Shapkin MA. Perioperative management of patients with diabetes mellitus. Anesteziologiya i reanimatologiya. 2016;61(4):290-293. (In Russ.). https://doi.org/10.18821/0201-7563-2016-4-290-293
  9. Dasanu CA, Shimanovsky A, Rotundo EK, Posteraro AF, Cooper DL, Atienza JA. Collision tumors: pancreatic adenocarcinoma and mantle cell lymphoma. JOP. 2013;14(4):458-462.  https://doi.org/10.6092/1590-8577/1533
  10. Pokataev IA, Gladkov OA, Zagainov VE, Kudashkin NE, Kuchin DM, Lyadov VK, Podluzhny DV, Tryakin AA, Fedyanin MYu, Chernykh MV. Practical recommendations for drug treatment of pancreatic cancer. Malignant tumors. 2022;12(3s2-1):530-544. (In Russ.). https://doi.org/10.18027/2224-5057-2021-11-3s2-27
  11. Fendrich V, Waldmann J, Bartsch DK, Schlosser K, Rothmund M, Gerdes B. Multiple primary malignancies in patients with sporadic pancreatic endocrine tumors. Journal of Surgical Oncology. 2008;97(7):592-595.  https://doi.org/10.1002/jso.21044
  12. Paklina OV, Setdikova GR, Rotin DL. Key moments of morphological examination of pancreatic tumors considering modern morphological classification. Annals of HPB Surgery. 2019;24(3):12-21. (In Russ.). https://doi.org/10.16931/1995-5464.2019312-21
  13. Kodaganur S, Hosamani IR. Synchronous malignancies of the gall bladder and common bile duct: a case report. World Journal of Surgical Oncology. 2016;14:106.  https://doi.org/10.1186/s12957-016-0848-y
  14. Luo J. KRAS mutation in pancreatic cancer. Seminars in Oncology. 2021;48(1):10-18.  https://doi.org/10.1053/j.seminoncol.2021.02.003
  15. Wang X, Allen S, Blake JF, Bowcut V, Briere DM, Calinisan A, Dahlke JR, Fell JB, Fischer JP, Gunn RJ, Hallin J, Laguer J, Lawson JD, Medwid J, Newhouse B, Nguyen P, O’Leary JM, Olson P, Pajk S, Rahbaek L, Rodriguez M, Smith CR, Tang TP, Thomas NC, Vanderpool D, Vigers GP, Christensen JG, Marx MA. Identification of MRTX1133, a Noncovalent, Potent, and Selective KRASG12D Inhibitor. Journal of Medicinal Chemistry. 2022;65(4):3123-3133. https://doi.org/10.1021/acs.jmedchem.1c01688
  16. Shen H, Lundy J, Strickland AH, Harris M, Swan M, Desmond C, Jenkins BJ, Croagh D. KRAS G12D Mutation Subtype in Pancreatic Ductal Adenocarcinoma: Does It Influence Prognosis or Stage of Disease at Presentation? Cells. 2022;11(19):3175. https://doi.org/10.3390/cells11193175
  17. Sedakov IE, Ishchenko RV, Antipov VN, Pivovarov NN, Bondar AV, Kolomiets KS. Short-term results of regional chemotherapy in locally advanced cancer of the head of the pancreas. Neoplasm. 2019;1(24):15-20. (In Russ.). https://doi.org/10.26435/neoplasm.v11i1.270
  18. Setdikova GR Karpov AA, Paklina OV, Knyshinsky GV, Tavobilov MM, Shabunin AV. Morphological background of intraoperative radiation therapy appliance to prevent locoregional progression in patients with pancreatic ductal adenocarcinoma. Malignant Tumours. 2017;(1):52-60. (In Russ.). https://doi.org/10.18027/2224-5057-2017-1-52-60

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.